Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck KGaA synthesizes novel FSH receptor agonists

Feb. 12, 2013

Pfizer presents new GPR119 receptor agonists

Feb. 12, 2013

French group synthesizes new imino-sugar derivatives

Feb. 12, 2013

Synageva BioPharma begins phase III ARISE trial

Feb. 12, 2013

Bristol-Myers Squibb patents new Y4 receptor agonists

Feb. 12, 2013

Novo Nordisk receives complete response letter for Tresiba and Ryzodeg

Feb. 11, 2013

Glucokinase plus insulin genetic therapy cures diabetes in dogs

Feb. 11, 2013

AstraZeneca patents new MCH1 receptor antagonists

Feb. 11, 2013

Novel DPP IV inhibitors synthesized at Boehringer Ingelheim

Feb. 11, 2013

Xenon receives Glybera approval milestone payment

Feb. 6, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...